ClinicalTrials.Veeva

Menu

Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy (SDLNOC)

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Lymph Node Metastases
Ovarian Cancer Stage IV

Treatments

Procedure: debulking surgery

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

To evaluate the survival impact of extensive lymphadenectomy as part of debulking surgery in stage IVB ovarian cancer with supradiaphragmatic lymph node metastasis.

Enrollment

121 patients

Sex

Female

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically diagnosed ovarian, fallopian tubal, primary peritoneal cancer
  • Patients suspected of metastatic lymph nodes in the cardiophrenic, internal mammary, and/or supraclavicular lymph node by CT (size larger than 5mm)
  • Patients clinically diagnosed FIGO stage IVB ovarian, fallopian tubal, primary peritoneal cancer
  • Patients underwent debulking surgery (primary debulking surgery or interval debulking surgery) at Seoul National University Hospital from January 2010 to January 2020
  • Patients age 18-90

Exclusion criteria

  • Borderline or benign ovarian disease
  • Patient didn't undergo debulking surgery
  • Non-epithelial ovarian cancer

Trial contacts and locations

1

Loading...

Central trial contact

Park Soo Jin, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems